Hong Kong Stock Market Abnormal Movement | Sino Biopharmaceutical Limited (02410.HK) Soared Over 10% in the Morning, Company Announced the Results of Phase II Clinical Trial of Editinib Tablets for Non-Small Cell Lung Cancer
Zh tng cijng APP hu xn, tng yun kng y yo -B (02410.HK) zo pn zhng cho 10%, jizh fgo, zhng 4.78%, bo 18.2 gngyun, chngjio r 3220.51 wn gngyun.
According to the financial news app Zh tng cijng, Tongyuan Kangyiyao -B (02410.HK) rose more than 10% in the morning trading session. As of the time of publication, it has risen by 4.78% to 18.2 Hong Kong dollars, with a trading volume of 32.2051 million Hong Kong dollars.
Latest